An animal model for intractable chronic lymphocytic leukemia

Schrek, 1962, Clinical evaluation of the in vitro test for radiosensitivity of leukemic lymphocytes, Blood, 20, 432, 10.1182/blood.V20.4.432.432 Shrek, 1958, Variability of the in vitro sensitivity of human leukemic lymphocytes to X-ray and chemotherapeutic agents, J Natl Cancer Inst, 20, 1037, 10.1093/jnci/20.6.1037 Shrek, 1974, Cytoxicity of vincristine to normal and leukemic cells, Am. J. Clin. Path., 62, 1, 10.1093/ajcp/62.1.1 Schrek, 1964, Prednisolone sensitivity and cytology of viable lymphocytes as tests for chronic lymphocytic leukemia, J. Natl. Cancer Inst., 33, 837, 10.1093/jnci/33.5.837 Shrek, 1988, Intractable chronic lymphocytic leukemia, J. Natl. Cancer Inst., 80, 604, 10.1093/jnci/80.8.604 Schrek, 1990, Differences between responsive and intractable chronic lymphocytic leukemia, Medical Hypotheses, 31, 81, 10.1016/0306-9877(90)90001-U Pegourie, 1987, Splenectomy during chronic lymphocytic leukemia, Cancer, 59, 1626, 10.1002/1097-0142(19870501)59:9<1626::AID-CNCR2820590917>3.0.CO;2-W Cheson, 1988, Response, J. Natl. Cancer Inst., 80, 604, 10.1093/jnci/80.8.604-a Begin, 1987, Effects of C18 fatty acids on breast carcinoma cells in culture, Anticancer Research, 7, 215 Begin, 1986, Differential filling of human carcinoma cells supplemented with n-3 and n-6 polyunsaturated fatty acids, J. Nat. Cancer Inst., 77, 1053 Elrod, 1966, In vitro reactions of lymphocytes from normal mice and from viral and X-ray-induced lymphomas, Cancer Research, 26, 1324